These findings might lead to novel therapeutic strategies for CRC liver metastasis and its recurrence by manipulating peritoneal GATA6 + macrophages and considering the intraperitoneal cavity as a more effective route of drug administration. This evidence concerns the gene GATA6 and colorectal carcinoma.